France to expand access to weight-loss drugs for obesity patients, AFP reports citing sources
- France will soon reimburse 65% of the cost of weight-loss drugs Wegovy (NOVOB DC) and Mounjaro (LLY) for severely obese patients, two informed sources told AFP.
- Health Minister to announce the scheme before its publication in the official journal of new legislation.
#FRANCE#ELI LILLY & CO#LLY.US#NOVO NORDISK A/S#NOVOB.DC#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#US EQUITIES